NO20041035L - 1-glyoxlyamidindolizin for behandling av kreft - Google Patents

1-glyoxlyamidindolizin for behandling av kreft

Info

Publication number
NO20041035L
NO20041035L NO20041035A NO20041035A NO20041035L NO 20041035 L NO20041035 L NO 20041035L NO 20041035 A NO20041035 A NO 20041035A NO 20041035 A NO20041035 A NO 20041035A NO 20041035 L NO20041035 L NO 20041035L
Authority
NO
Norway
Prior art keywords
substituted
group
unsubstituted
independently
aryl group
Prior art date
Application number
NO20041035A
Other languages
English (en)
Norwegian (no)
Inventor
Mitsunori Ono
Keizo Koya
Lijun Sun
Weiwen Ying
Hao Li
Original Assignee
Synta Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synta Pharmaceuticals Corp filed Critical Synta Pharmaceuticals Corp
Publication of NO20041035L publication Critical patent/NO20041035L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20041035A 2001-09-13 2004-03-11 1-glyoxlyamidindolizin for behandling av kreft NO20041035L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32202001P 2001-09-13 2001-09-13
PCT/US2002/029154 WO2003022846A1 (en) 2001-09-13 2002-09-13 1-glyoxlylamide indolizines for treating cancer

Publications (1)

Publication Number Publication Date
NO20041035L true NO20041035L (no) 2004-04-30

Family

ID=23253054

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041035A NO20041035L (no) 2001-09-13 2004-03-11 1-glyoxlyamidindolizin for behandling av kreft

Country Status (19)

Country Link
US (2) US6861436B2 (enExample)
EP (1) EP1432709B8 (enExample)
JP (1) JP2005504795A (enExample)
KR (1) KR20040053125A (enExample)
CN (1) CN1568324A (enExample)
AT (1) ATE300542T1 (enExample)
AU (1) AU2002333626B2 (enExample)
BR (1) BR0212794A (enExample)
CA (1) CA2459886A1 (enExample)
DE (1) DE60205265T2 (enExample)
ES (1) ES2245747T3 (enExample)
IL (1) IL160810A0 (enExample)
IS (1) IS7176A (enExample)
MX (1) MXPA04002323A (enExample)
NO (1) NO20041035L (enExample)
NZ (1) NZ531700A (enExample)
PT (1) PT1432709E (enExample)
WO (1) WO2003022846A1 (enExample)
ZA (1) ZA200401996B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160810A0 (en) * 2001-09-13 2004-08-31 Synta Pharmaceuticals Corp 1-glyoxlylamide indolizines for treating cancer
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds
WO2004024727A2 (en) * 2002-09-13 2004-03-25 Synta Pharmaceuticals Corp. Synthesis of indolizines
DE10318611A1 (de) 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
WO2005099824A1 (en) * 2004-03-30 2005-10-27 Synta Pharmaceuticals, Corp. 1-glyoxylamide indolizines for treating lung and ovarian cancer
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
WO2006073938A2 (en) * 2004-12-30 2006-07-13 East Carolina University Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20060293345A1 (en) * 2005-05-20 2006-12-28 Christoph Steeneck Heterobicyclic metalloprotease inhibitors
US8404736B2 (en) * 2008-08-14 2013-03-26 Beta Pharma Canada Inc. Heterocyclic amide derivatives as EP4 receptor antagonists
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
CN113603694B (zh) * 2021-07-16 2022-07-22 浙江工业大学 一种1,2-二酮类化合物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2287706A (en) 1994-03-21 1995-09-27 Fujisawa Pharmaceutical Co Indolizine derivatives
FR2757166B1 (fr) * 1996-12-12 1999-01-29 Rhone Poulenc Rorer Sa Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO1998047507A1 (en) 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
KR20010034881A (ko) 1998-05-21 2001-04-25 시오노 요시히코 sPLA2 억제 효과를 갖는 피롤로[1,2-b]피리다진 유도체
ATE329619T1 (de) 1998-10-14 2006-07-15 Shionogi & Co Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden
US6461538B2 (en) * 1999-12-16 2002-10-08 Fuji Photo Film Co., Ltd. Production process for indolizine compounds and their use in organic light-emitting devices
IL160810A0 (en) * 2001-09-13 2004-08-31 Synta Pharmaceuticals Corp 1-glyoxlylamide indolizines for treating cancer
US20040116462A1 (en) * 2002-12-12 2004-06-17 Mitsunori Ono Indolizine compounds

Also Published As

Publication number Publication date
EP1432709B1 (en) 2005-07-27
PT1432709E (pt) 2005-10-31
IS7176A (is) 2004-03-11
CN1568324A (zh) 2005-01-19
AU2002333626B2 (en) 2006-06-29
DE60205265T2 (de) 2006-03-30
NZ531700A (en) 2006-10-27
JP2005504795A (ja) 2005-02-17
EP1432709B8 (en) 2005-11-02
EP1432709A1 (en) 2004-06-30
ES2245747T3 (es) 2006-01-16
ZA200401996B (en) 2005-05-31
US6861436B2 (en) 2005-03-01
US20040214850A1 (en) 2004-10-28
US20030153759A1 (en) 2003-08-14
CA2459886A1 (en) 2003-03-20
IL160810A0 (en) 2004-08-31
KR20040053125A (ko) 2004-06-23
DE60205265D1 (de) 2005-09-01
MXPA04002323A (es) 2005-04-08
WO2003022846A1 (en) 2003-03-20
HK1063322A1 (en) 2004-12-24
BR0212794A (pt) 2004-10-05
ATE300542T1 (de) 2005-08-15

Similar Documents

Publication Publication Date Title
IS7176A (is) 1-Glýoxlýlamíd-indólízín til meðhöndlunar á krabbameini
NO20050418L (no) Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet
PE20030746A1 (es) DERIVADOS DE PIRIDO [2,1-a] ISOQUINOLINA
CO5590895A2 (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos
YU48390B (sh) Novi derivati 2-anilinopirimidina, postupak za njihovo dobijanje i sredstva za uništavanje štetočina, koja sadrže ove derivate
AR049769A1 (es) Derivados de pirazolo(1,5-a)pirimidin 7-il-amina para utilizarse en el tratamiento de enfermedades dependientes de la quinasa de proteina
MEP57408A (en) Quinoline derivatives
EA200700141A1 (ru) Новые аминоциклические производные мочевины, их получение и фармацевтическое применение в качестве ингибиторов киназы
CO5580826A2 (es) Compuestos de quinolona terapeuticos con propiedades antagonistas de 5ht
AR023152A1 (es) Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion
AR040626A1 (es) Derivados de quinolina utiles como ligandos del receptor del neuropeptido y (npy)
ES8706146A1 (es) Un procedimiento para preparar derivados de piridina
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
AR043487A1 (es) Heterociclos fusionados de pirimidina y usos de los mismos
DK471586D0 (da) 3-vinyl- og 3-ethynyl-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
HUP0201475A2 (hu) Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DK118287D0 (da) Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
CO5690577A2 (es) Derivados de imidazoquinolina como ligandos receptores de adenosina a3
DK0712395T3 (da) Fremgangsmåde til fremstilling af fluoralkenylthio-heterocykliske derivater
DK1303512T3 (da) Fremgangsmåde til fremstilling af arylacetylaminothiazoler
DK0599240T3 (da) Indol-7-carboxamidderivater som analgetika
ATE90678T1 (de) Phenoxy-substituierte beta-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel.
AR036735A1 (es) Derivados de 5-metoxi-8-aril-[1,2,4]triazolo[1,5-a]piridina
TW200602039A (en) 1-Glyoxylamide indolizines for treating lung and ovarian cancer
ES435955A1 (es) Un procedimiento para obtener un derivado de pirido (3,4-d) piridezina.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application